Induction of intestinal damage by rofecoxib, the selective COX-2 inhibitor, under inhibition of nitric oxide production in rats

Author： Ohno Ryoko Miyazawa Tohru Hayashi Yujiro Kanatsu Kenji Tanaka Akiko Takeuchi Koji

Publisher： VSP

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.10, Iss.4-6, 2002-12, pp. : 435-447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

We examined whether intestinal damage is provoked in rats under inhibition of both cNOS and COX-2. SC-560, rofecoxib or L-NAME was given either alone or in combination, and the animals were killed 24 h later. Neither SC-560 nor rofecoxib alone provoked damage in the small intestinal mucosa. However, SC-560 produced gross lesions when administered together with rofecoxib. Likewise, L-NAME alone did not cause damage, but this agent provoked gross lesions when administered together with rofecoxib. Mucosal PGE₂ content was decreased by SC-560 but not by rofecoxib and L-NAME. The expression of COX-2 was upregulated by L-NAME as well as by SC-560. Both L-NAME and SC-560 enhanced intestinal motility, decreased mucus secretion, and increased the enterobacterial number in the mucosa. We conclude that inhibition of both cNOS and COX-2 provokes intestinal damage. Inhibition of cNOS up-regulates COX-2 expression, and this may be a key to occurrence of intestinal damage associated with COX-2 inhibition.